BioNova Pharmaceuticals (Shanghai) Ltd. is a privately-held clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative medicines for cancer and other life-threatening diseases with high unmet medical needs. Headquartered in Shanghai, BioNova is a fast-growing company with a robust pipeline built on internal R&D programs, collaborations with, and acquisitions from partners of cutting-edge technology. With a highly capable and seasoned team in combination with substantial funding, BioNova is committed to delivering high-quality innovative medicines to patients in China and globally.